How Much Weight Can You Lose on GLP-1 Medication?
Hemyrx Team
Cotent Editor

How much weight can you lose on GLP-1 medication? Most lose 10 to 20% over 12 to 18 months. See semaglutide vs tirzepatide results and timelines.
Most people lose between 10 and 20 percent of their body weight on GLP-1 medication over 12 to 18 months. In clinical trials, semaglutide produced about 15 percent average weight loss and tirzepatide about 21 percent at top doses. Results depend on the drug, the dose reached, and how closely diet, activity and the weekly schedule are followed. Weight comes off gradually, not overnight and a clinician adjusts the plan to your response.
How much weight can you lose on GLP-1 medication?
How much weight you can lose on GLP-1 medication ranges from about 10 to 20 percent of starting body weight for most people over roughly 12 to 18 months. For a 220-pound adult, that translates to about 22 to 44 pounds. The top of that range usually requires reaching the highest tolerated dose and pairing the medication with reduced calorie intake and regular activity. Trial averages are not guarantees, and some people lose less while a smaller group loses more, so a realistic target is set with a clinician rather than from a headline number.
Averages hide a wide spread. In the main weight-management trials, roughly one in three adults on tirzepatide lost a quarter or more of their body weight, while others on the same dose lost far less. Genetics, starting weight, diet, sleep, other medications, and consistency all move the result. A licensed clinician in our online weight loss program sets an individual goal based on your health profile, because a number that suits one patient can be wrong for another.
What is GLP-1 medication and how does it cause weight loss?
GLP-1 medication is a class of prescription drugs that mimics glucagon-like peptide-1, a gut hormone released after eating. The medication slows stomach emptying, steadies blood sugar, and signals fullness to the brain, so most patients feel satisfied on smaller portions and snack less between meals. The result is a steady calorie deficit that drives fat loss over months. Semaglutide and tirzepatide are the two most common GLP-1-based options for weight, both taken as a once-weekly injection that builds in dose over time.
Weight loss comes from reduced appetite, not from the drug burning fat directly. Because hunger and food noise drop, the everyday struggle of eating less becomes more manageable, which is why adherence improves for many people. According to the National Institute of Diabetes and Digestive and Kidney Diseases, these medications are intended for long-term use alongside lifestyle changes, not as a brief course. The appetite effect fades if the medication stops, which is why a maintenance plan matters as much as the initial loss.
How much can you lose on semaglutide versus tirzepatide?
Semaglutide and tirzepatide differ in average weight loss, with tirzepatide leading in head-to-head data. Semaglutide 2.4 mg produced about 14.9 percent average body-weight reduction over 68 weeks in the STEP-1 trial. Tirzepatide 15 mg produced about 20.9 percent over 72 weeks in SURMOUNT-1. A 2025 trial that compared the two directly found greater loss with tirzepatide. The FDA approved semaglutide for chronic weight management in 2021 and tirzepatide in 2023, and both also have lower doses that deliver smaller but meaningful results for patients who cannot tolerate or do not need the maximum dose.
The table below summarizes typical trial results so the ranges are easy to compare. Numbers reflect study averages with diet and activity support, not promised outcomes for any individual.
| Medication | Top dose | Average weight loss | Trial duration |
|---|---|---|---|
| Semaglutide (Wegovy) | 2.4 mg weekly | ~15% of body weight | 68 weeks |
| Tirzepatide (Zepbound) | 15 mg weekly | ~21% of body weight | 72 weeks |
| Lower-dose tirzepatide | 5 mg weekly | ~15% of body weight | 72 weeks |
| Lifestyle alone (placebo) | n/a | ~2 to 3% of body weight | 68 to 72 weeks |
The placebo row matters because it shows how much the medication adds on top of diet and activity alone. A clinician uses these benchmarks to set expectations and to decide which drug and dose suit your goal.
How fast does GLP-1 weight loss happen?
GLP-1 weight loss is gradual and follows the slow dose increase, so the first weeks bring modest change while the appetite effect builds. Most people lose a few pounds in the first month during the lowest starting dose, then see the rate pick up as the dose climbs over three to five months. Meaningful loss of around 5 percent often appears by month three, with the largest reductions arriving between months six and eighteen. Rapid early loss is uncommon and not the goal, because steady fat loss is safer and easier to sustain.
The approximate timeline below reflects average progress on a full titration schedule. Individual pace varies, and a plateau at any stage is normal rather than a sign of failure.
| Time on treatment | Typical cumulative loss | What is happening |
|---|---|---|
| Month 1 | 2 to 5 pounds | Lowest starting dose, appetite effect beginning |
| Month 3 | About 5% of body weight | Dose increasing, hunger noticeably lower |
| Month 6 | About 10% of body weight | Approaching or at maintenance dose |
| Months 12 to 18 | 15 to 21% of body weight | Peak average loss, plan shifts to maintenance |
Knowing how online treatment works helps set the right pace from the start, and our online treatment process schedules follow-ups around these milestones. Consistency through each dose step is what carries results into the higher range.
What affects how much weight you lose?
Several factors decide where you land in the 10 to 20 percent range, and most are within reach. The dose you tolerate matters most, since the largest results come at the higher maintenance doses. Diet quality and protein intake protect muscle and improve the quality of the loss. Physical activity, sleep, stress, other medications, and starting weight all play a part. Consistency with the weekly injection is decisive, because skipped weeks blunt the appetite effect and stall progress that took months to build.
Adherence is the factor patients control most directly. People who keep the weekly schedule, reach an effective dose, and adjust eating habits consistently tend to land near the top of the range, while frequent gaps or an early stop pull results lower. A clinician fine-tunes the plan when progress stalls, and patients can start a private online assessment to get a dose and follow-up schedule matched to their situation.
Will you regain weight after stopping GLP-1?
Weight regain after stopping a GLP-1 medication is common because the appetite-lowering effect ends when the drug does. In studies, many people regained a large share of lost weight within about a year of stopping. Obesity behaves as a chronic condition, so treatment that works while taken often loses ground once paused, much like blood pressure medication. A clinician decides whether to continue, lower the dose, or build a maintenance plan, rather than treating the course as a one-time fix that ends at goal weight.
Is online GLP-1 weight-loss treatment safe and legit?
Online GLP-1 treatment is legitimate and safe when a licensed clinician reviews your history, prescribes appropriately, and provides follow-up care. Reputable telehealth providers require a real medical assessment, use licensed U.S. pharmacies, and adjust dosing over time rather than shipping a fixed plan. The convenience suits a weekly, months-long treatment that needs monitoring, not a single visit. Warning signs of an unsafe service include no clinician review, no follow-up, and any promise of a guaranteed amount of weight loss, which no honest provider offers.
Trust comes from the process, not the marketing. A safe program screens for the conditions that make GLP-1 medication risky, explains side effects and injection technique, and stays available as the dose climbs. Our physician-guided GLP-1 program follows that model, with a licensed clinician overseeing every plan from the first assessment through maintenance.

When might GLP-1 not be right for you?
GLP-1 medication is not appropriate for everyone, and honest screening keeps it safe. Avoid these drugs entirely if you have a personal or family history of medullary thyroid cancer or multiple endocrine neoplasia type 2. Use caution and clinician guidance if you have a history of pancreatitis, gallbladder disease, severe gastrointestinal problems, or diabetic eye disease, or if you are pregnant or trying to conceive. Seek urgent care for severe, persistent abdominal pain that may spread to the back, which can signal pancreatitis. A clinical assessment confirms whether the medication fits your health.
HemyRx's online weight-loss program
HemyRx is a direct-to-consumer telehealth provider that connects U.S. patients with licensed clinicians for prescription weight management and five other conditions. Weight management is one of its two priority programs, alongside hemorrhoid and fissure treatment. The path is private by design: an online assessment, a clinician review of your history, and discreet shipping if treatment is approved, followed by scheduled check-ins as the dose increases.
Realistic care defines the brand. HemyRx does not advertise a fixed number on the scale, because results depend on the medication, the dose, and the habits around it. Each plan is clinician-reviewed, dosing follows the manufacturer titration schedule, and patients receive injection guidance and ongoing support through the months a GLP-1 course requires.
Frequently Asked Questions
How much weight can I lose on GLP-1 in 3 months?
Most people lose around 5 percent of body weight by month three on a GLP-1 medication, often 8 to 15 pounds depending on starting weight. Early loss is modest because the dose is still increasing. The rate usually picks up after month three as the dose climbs toward maintenance and appetite control strengthens.
Can I lose 20 percent of my body weight on GLP-1?
Reaching about 20 percent is realistic for some patients, mainly on higher-dose tirzepatide, where trials averaged near 21 percent. Hitting that level usually requires the top tolerated dose, full diet and activity support, and 12 to 18 months of consistent use. Many people land closer to 10 to 15 percent, which still brings real health benefits.
How fast will I see results on GLP-1 medication?
Most people notice reduced appetite within the first few weeks and lose a few pounds in the first month. Visible, steady weight loss usually builds from month two onward as the dose increases. Rapid early loss is uncommon and not the aim, since gradual loss is safer and easier to maintain over time.
Do I keep the weight off after stopping?
Keeping weight off after stopping is hard because appetite returns when the medication ends, and studies show significant regain within a year for many people. Obesity is a chronic condition, so most patients need a long-term or maintenance plan. A clinician decides whether to continue, reduce, or adjust treatment rather than stopping abruptly at goal.
Is GLP-1 weight loss permanent?
GLP-1 weight loss is maintained while the medication and habits continue, but it is not automatically permanent. The drug controls appetite rather than resetting it for good, so stopping often leads to partial regain. Long-term results come from a sustained plan that may include ongoing medication, dietary changes, and regular clinician follow-up.
Final Thoughts
Most people lose 10 to 20 percent of their body weight on GLP-1 medication over 12 to 18 months, with tirzepatide averaging higher than semaglutide in trials. The amount depends on the dose reached, the habits around it, and consistency with the weekly schedule, and the weight returns for many people who stop without a maintenance plan. Honest care sets a realistic target and treats weight as a long-term condition, not a quick fix.
The best way to learn your own realistic range is a clinical assessment. To have a licensed clinician review your history and build a plan around your goal, start with the HemyRx GLP-1 weight loss program and take the online assessment today.
